Nasdaq · Industrials
Akso Health Group (AHG)
As-reported financials and recent SEC filings for Akso Health Group, latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$14.8M
Net income
$-135.0M
Net margin
—
Diluted EPS
$-0.16
ROE
-67.8%
P/E (TTM)
—
Market cap
—
Debt / equity
—
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $14.8M | $2.4M | $13.2M | $6.0M | $1.8M |
| Gross profit | $-281,526 | $122,132 | $1.3M | $605,134 | $1.2M |
| Operating income | $-166.3M | $-8.6M | $-14.3M | $-3.3M | $-4.2M |
| Net income | $-135.0M | $-9.5M | $-1.4M | $-16.9M | $-34.8M |
| Diluted EPS | $-0.16 | $-0.01 | $-0.00 | $-0.02 | $-0.06 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
6-K2026-05-13
View on EDGAR →32026-04-06
View on EDGAR →32026-03-30
View on EDGAR →32026-03-27
View on EDGAR →6-K2026-03-23
View on EDGAR →32026-03-18
View on EDGAR →32026-03-18
View on EDGAR →32026-03-18
View on EDGAR →Largest Industrials peers
Go deeper on AHG
Search Akso Health Group’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeOr check your whole portfolio free — no account needed.
Data sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.